{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,18]],"date-time":"2026-06-18T20:59:34Z","timestamp":1781816374502,"version":"3.54.5"},"reference-count":0,"publisher":"Clinical Care Targeted Communications Group, LLC","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,6,1]]},"DOI":"10.37765\/ajmc.2026.89955","type":"journal-article","created":{"date-parts":[[2026,6,18]],"date-time":"2026-06-18T20:48:58Z","timestamp":1781815738000},"page":"353","source":"Crossref","is-referenced-by-count":0,"title":["Combined Pharmacotherapy and Psychotherapy Impact on Opioid Use Disorder Treatment"],"prefix":"10.37765","volume":"32","member":"24492","published-online":{"date-parts":[[2026,6,1]]},"container-title":["The American Journal of Managed Care"],"original-title":[],"deposited":{"date-parts":[[2026,6,18]],"date-time":"2026-06-18T20:48:58Z","timestamp":1781815738000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ajmc.com\/view\/combined-pharmacotherapy-and-psychotherapy-impact-on-opioid-use-disorder-treatment"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,1]]},"references-count":0,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2026,6,1]]},"published-print":{"date-parts":[[2026,6,1]]}},"URL":"https:\/\/doi.org\/10.37765\/ajmc.2026.89955","relation":{},"ISSN":["1088-0224","1936-2692"],"issn-type":[{"value":"1088-0224","type":"print"},{"value":"1936-2692","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,1]]}}}